Cost-effectiveness analysis of cetuximab for the treatment of head and neck cancers in India

Nidhi Gupta, Jyoti Dixit, Gaurav Jyani, Shankar Prinja

Open source

DOI: 10.3389/fphar.2026.1948615
Published: 2026-10-23
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1948615,
  title = {Cost-effectiveness analysis of cetuximab for the treatment of head and neck cancers in India},
  author = {Nidhi Gupta and Jyoti Dixit and Gaurav Jyani and Shankar Prinja},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1948615},
  url = {https://doi.org/10.3389/fphar.2026.1948615}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness analysis of cetuximab for the treatment of head and neck cancers in India
AU  - Nidhi Gupta
AU  - Jyoti Dixit
AU  - Gaurav Jyani
AU  - Shankar Prinja
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1948615
UR  - https://doi.org/10.3389/fphar.2026.1948615
ER  -

APA

Gupta, N., Dixit, J., Jyani, G., & Prinja, S. (2026). Cost-effectiveness analysis of cetuximab for the treatment of head and neck cancers in India. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1948615

Source records

crossref · retrieved 2026-11-09T15:40:31.770Z